![](https://www.diabetesnews.com/wp-content/uploads/2012/04/eye-150x150.jpg)
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema suggests the greater efficacy of bevacizumab compared with macular laser therapy
Read more
A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema suggests the greater efficacy of bevacizumab compared with macular laser therapy
Read more